Relative Value Partners Group, LLC Abb Vie Inc. Transaction History

Relative Value Partners Group, LLC

$751 Million
Q2 2024

A detailed history of Relative Value Partners Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Relative Value Partners Group, LLC holds 29,525 shares of ABBV stock, worth $5.2 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares

29,525

Previous 10,298 186.71%

Holding current value

$5.2 Million

Previous $1.88 Million 170.08%

% of portfolio

0.67%

Previous 0.12%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 12, 2024	BUY	$154.79 - $180.76 $2.98 Million - $3.48 Million	19,227 Added 186.71%	29,525 $5.06 Million
Q1 2024 May 13, 2024	SELL	$159.82 - $182.1 $26,210 - $29,864	-164 Reduced 1.57%	10,298 $1.88 Million
Q4 2023 Feb 12, 2024	SELL	$137.6 - $154.97 $17,612 - $19,836	-128 Reduced 1.21%	10,462 $1.62 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $281,874 - $326,311	2,110 Added 24.88%	10,590 $1.58 Million
Q2 2023 Aug 11, 2023	SELL	$132.51 - $164.9 $236,397 - $294,181	-1,784 Reduced 17.38%	8,480 $1.14 Million
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $92,116 - $106,085	-637 Reduced 5.84%	10,264 $1.64 Million
Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $504,554 - $605,093	3,648 Added 50.3%	10,901 $1.76 Million
Q3 2022 Nov 10, 2022	BUY	$134.21 - $153.93 $973,425 - $1.12 Million	7,253 New	7,253 $973,000
Q2 2022 Aug 11, 2022	SELL	$137.62 - $174.96 $1.3 Million - $1.66 Million	-9,473 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $485,026 - $601,781	3,675 Added 63.38%	9,473 $1.54 Million
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $57,349 - $65,100	-539 Reduced 8.51%	5,798 $625,000
Q2 2021 Aug 12, 2021	SELL	$105.21 - $117.21 $165,284 - $184,136	-1,571 Reduced 19.87%	6,337 $714,000
Q1 2021 May 12, 2021	BUY	$102.3 - $112.62 $12,071 - $13,289	118 Added 1.51%	7,908 $856,000
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $138,845 - $187,455	1,725 Added 28.44%	7,790 $835,000
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $24,432 - $32,693	333 Added 5.81%	6,065 $595,000
Q1 2020 May 13, 2020	BUY	$64.5 - $97.79 $214,978 - $325,934	3,333 Added 138.93%	5,732 $436,000
Q4 2019 Feb 13, 2020	BUY	$72.13 - $90.25 $173,039 - $216,509	2,399 New	2,399 $212,000
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $254,628 - $306,135	-4,043 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$65.7 - $83.98 $68,985 - $88,179	1,050 Added 35.08%	4,043 $294,000
Q1 2019 May 14, 2019	BUY	$77.14 - $90.79 $230,880 - $271,734	2,993 New	2,993 $241,000
Q4 2018 Feb 11, 2019	SELL	$77.85 - $96.01 $156,556 - $193,076	-2,011 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$88.91 - $98.84 $178,798 - $198,767	2,011 New	2,011 $190,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $312B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Relative Value Partners Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Relative Value Partners Group, LLC with notifications on news.

Account

Relative Value Partners Group, LLC Abb Vie Inc. Transaction History